Literature DB >> 30753913

Modulation of tonic immobility by GABAA and GABAB receptors of the medial amygdala.

Bruna B de Paula1, Jeanne R de Melo1, Christie R A Leite-Panissi2.   

Abstract

Tonic immobility (TI) is a temporary state of profound motor inhibition associated with great danger as the attack of a predator. Previous studies carried out in our laboratory evidenced high Fos-IR in the posteroventral region of the medial nucleus of the amygdala (MEA) after induction of the TI response. Here, we investigated the effects of GABAA and GABAB of the MEA on TI duration. Intra-MEA injections of the GABAA agonist muscimol and GABAB agonist baclofen reduced TI response, while intra-MEA injections of the GABAA antagonist bicuculline and GABAB antagonist phaclofen increased the TI response. Moreover, the effects observed with muscimol and baclofen administrations into MEA were blocked by pretreatment with bicuculline and phaclofen (at ineffective doses per se). Finally, the activation of GABAA and GABAB receptors in the MEA did not alter the spontaneous motor activity in the open field test. These data support the role of the GABAergic system of the MEA in the modulation of innate fear.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amygdala; Defensive behavior; GABA; Innate fear

Year:  2019        PMID: 30753913     DOI: 10.1016/j.neulet.2019.01.054

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  2 in total

1.  Role of the GABAa and GABAb receptors of the central nucleus of the amygdala in compulsive cocaine-seeking behavior in male rats.

Authors:  WenLin Sun; Matt B Yuill
Journal:  Psychopharmacology (Berl)       Date:  2020-09-01       Impact factor: 4.530

2.  Case Report: GABAergic and Serotoninergic Agents for the Treatment and Prevention of Prolonged Dissociative Stupor.

Authors:  Daisuke Yoshioka; Masaaki Iwata; Koichi Kaneko
Journal:  Front Psychiatry       Date:  2021-05-19       Impact factor: 4.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.